Deerfield Management Company, L.P. (Series C) Twist Bioscience Corp Transaction History
Deerfield Management Company, L.P. (Series C)
- $5.38 Billion
- Q3 2024
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Twist Bioscience Corp stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 23,424 shares of TWST stock, worth $864,111. This represents 0.02% of its overall portfolio holdings.
Number of Shares
23,424
Previous 19,456
20.39%
Holding current value
$864,111
Previous $958,000
10.44%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding TWST
# of Institutions
256Shares Held
66.8MCall Options Held
127KPut Options Held
45.4K-
Artisan Partners Limited Partnership Milwaukee, WI6.02MShares$222 Million0.43% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.62MShares$207 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.42MShares$200 Million0.01% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.36MShares$198 Million2.3% of portfolio
-
Invesco Ltd. Atlanta, GA3.64MShares$134 Million0.03% of portfolio
About Twist Bioscience Corp
- Ticker TWST
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 56,363,500
- Market Cap $2.08B
- Description
- Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...